A dopamine-precursor-based nanoprodrug for in-situ drug release and treatment of acute liver failure by inhibiting NLRP3 inflammasome and facilitating liver regeneration
Chenyue Zhan, Guifang Lin, Yong Huang, Ziqian Wang, Fang Zeng, Shuizhu Wu
Topics & Concepts
Regeneration (biology)DrugMaterials scienceInflammasomeDopamineIn situLiver regenerationPharmacologyLiver injuryLiver failureBiomedical engineeringCell biologyMedicineBiologyInflammationInternal medicineChemistryOrganic chemistryLiver Disease and TransplantationNanoplatforms for cancer theranosticsCOVID-19 Impact on Reproduction